InSilicoTrials’ Post

🚀 The field of Genetics is rapidly evolving, pushing the boundaries of modern medicine. As specialists in Genetics and Genomics Testing billing, we stay ahead of the curve, adapting to the latest developments and ensuring that we're always prepared to navigate the complexities of this specialized area. Our expertise lies in accurately and efficiently filing claims and securing reimbursements from insurance providers. With a deep understanding of the nuances in genetics billing, we're committed to delivering exceptional service in this ever-changing landscape. 💼🔬 🔍 Billing for Genetics is a highly specialized area that requires precise handling, starting from the pre-authorization phase. At SunKnowledge, we take pride in our proven and widely recognized platform, Prior Auth Online. Our goal is to streamline the prior authorization process and deliver the results you need in the shortest possible time. "Looking to streamline your operations? Schedule a free consultation to discover how Sunknowledge can seamlessly extend your team and drive efficiency. Reach out at +1 (646)-867-0267 or email maverick.johnson@sunknowledge.com to learn more!" We make the complexities of genetic billing manageable and efficient. 💻💡 #HealthcareBilling #Genetics #PriorAuthorization #SunKnowledge #Genomics #MedicalBilling #HealthcareInnovation

The year-end rush in biostatistics can be overwhelming. Tight deadlines, complex analyses, and reporting demands often create a perfect storm of stress and inefficiency. One effective way to mitigate this chaos is by collaborating closely with the right Contract Research Organization (CRO). By partnering with a CRO that understands your specific needs, has the right expertise, and maintains clear communication, you can navigate the busiest season with confidence and ensure high-quality results all year round. #biostatistics

🔴 #HappeningNow: If you are at the 19th BioPharma Clinical Trials Nexus in #Basel, come share a coffe with the #IDDI team of experts and we'll be happy to help you with your clinical study needs. Visit Booth #6! #biometricscro #clinicaldatascience #clinicaltrials #biostatistics #trialdesign #clinicaldatamanagement #randomization

I am happy to share that I received a certificate of participation for attending the webinar organized by #ISCR on the "Designs and Conduct of Clinical Trials, held in the honor of National Statistics Day. A big thank you to Mahendra Bijarnia, Ph.D. (Statistics) and Rahul Bhattacharyya for their insightful talks on role of Biostatistician in drug development, clinical trial statistics, randomization, and masking! This experience has greatly enhanced my understanding and appreciation of the detailed processes involved in Clinical Trials or Research. #ClinicalTrials #StatisticsDay #Biostatistician #Statistician #Statistics

With only 500 CPT codes currently being used to classify over 175,000 genetic tests, legacy payment and prior authorization approaches simply can no longer provide payers the quality insights necessary to appropriately identify and authorize tests against evidence-based policies. Avalon’s Precision Genetic Test Management solution unites evidence-based lab policies with automated policy adherence, accredited pre- and post-service clinically led reviews, and ensures appropriate, high-quality testing using discrete genetic codes for specificity. Learn how we’re helping health plans streamline prior authorization processes and reduce administrative burden with Precision Genetic Test Management: https://ow.ly/aCuN50S0bj8 #AvalonHCS #GeneticTesting #ValueDrivenCare #LabBenefitManagement

Congratulations to #UBuffalo Chair of Biostatistics, Douglas Landsittel, PhD, recently selected as a co-chair elect for the North American Biostatistics Chair (NABC) group. NABC is a group of 86 chairs of biostatistics departments who meet virtually on a quarterly basis and in-person at several statistical meetings to discuss challenges and opportunities facing biostatistics departments, and to weigh in on important issues. Landsittel has been active in the group since serving as chair at Indiana University and is currently taking the lead on a paper to propose guidelines for effort requirements of biostatisticians. #UBSPHHP #Stats #Statistics #StatsNews #Biostatistics

As a Biostatistician, I ensure meticulous handling of statistical inputs in clinical study reports, interpreting and conclusively presenting study data insights with precision. Gratitude to all presenters and the #ISCR Teams for their valuable contributions. #Biostatistician #SAS #clinicalresearch #Statistics #CSR #clinicaltrial

THE FUTURE OF GENETIC POLICY "𝓖𝓮𝓷𝓮𝓽𝓲𝓬 𝓹𝓸𝓵𝓲𝓬𝔂 𝓶𝓾𝓼𝓽 𝓫𝓮 𝓹𝓪𝓽𝓲𝓮𝓷𝓽-𝓬𝓮𝓷𝓽𝓮𝓻𝓮𝓭, 𝓮𝓷𝓼𝓾𝓻𝓲𝓷𝓰 𝓽𝓱𝓪𝓽 𝓲𝓷𝓭𝓲𝓿𝓲𝓭𝓾𝓪𝓵𝓼 𝓱𝓪𝓿𝓮 𝓬𝓸𝓷𝓽𝓻𝓸𝓵 𝓸𝓿𝓮𝓻 𝓽𝓱𝓮𝓲𝓻 𝓰𝓮𝓷𝓮𝓽𝓲𝓬 𝓭𝓪𝓽𝓪 𝓪𝓷𝓭 𝓪𝓬𝓬𝓮𝓼𝓼 𝓽𝓸 𝓵𝓲𝓯𝓮-𝓬𝓱𝓪𝓷𝓰𝓲𝓷𝓰 𝓽𝓱𝓮𝓻𝓪𝓹𝓲𝓮𝓼."— Sharon Terry 🧬 Genetic policy, encompassing laws and regulations related to genetic technologies and applications, plays a great role in shaping the ethical, social, and legal landscape of the future. As advancements in genetic research continue to accelerate, questions surrounding genetic policy have become increasingly complex and consequential. 🔹 One of the key issues in genetic policy is the regulation of genetic testing and screening. As genetic testing becomes more accessible and affordable, policymakers must grapple with questions of privacy, consent, and discrimination. Striking a balance between individuals' right to genetic information and the potential misuse of such data will be a paramount concern in the future of genetic policy. 🔹 Another important aspect of genetic policy is the regulation of genetic engineering technologies such as CRISPR-Cas9. The ability to edit the human genome raises profound ethical questions regarding enhancement, designer babies, and the potential for unintended consequences. Future genetic policy will need to establish clear guidelines for the responsible use of genetic engineering while fostering innovation and scientific progress. 🔹 In addition to ethical considerations, genetic policy also intersects with issues of social justice and equity. Ensuring access to genetic healthcare services for all populations, addressing disparities in genetic research, and protecting vulnerable populations from exploitation are essential goals for the future of genetic policy. Policymakers will need to work collaboratively with stakeholders to develop inclusive and equitable genetic policies. ⚠️ In an Oystershell, the future of genetic policy holds immense promise and challenges. By addressing ethical dilemmas, promoting innovation, and prioritizing equity, policymakers can shape a future where genetic technologies benefit society as a whole. As we navigate the complexities of genetic policy, it is essential to engage in thoughtful dialogue and decision-making to ensure that the future of genetic policy reflects our shared values and aspirations. #GeneticPolicy #FutureTech #EthicalDilemmas #Innovation #EquityInHealthcare #Bioethics #CRISPR #GeneticTesting #SocialJustice #PolicyDevelopment

CTDNA is a partner organisation of @rarevoicesaustralia - we encourage everyone involved in the heritable disorders of connective tissue community in Australia to complete this national survey. This study is being run to understand the priorities and concerns of Australian people, patients and their carers when it comes to genomic testing (DNA testing). An independent research company, CaPPRe, is hosting and running this ethics approved survey. The team that designed the survey includes the CaPPRe team, academic researchers, people who live with rare genetic conditions, their families and communities, patient/consumer organisations, and members of committees who make recommendations to the government about which tests and treatments should receive public funding. Please note - The survey does take some time, but you don’t need to complete the survey in one sitting. What's involved? Eligible Australian participants aged over 18 can complete the 25 minute online survey on their computer or large tablet device. To start the survey, please follow this link; https://lnkd.in/g68-T_nP If you would like more information about this study, please do not hesitate to contact maya.joshi@cappre.com.au If you are eligible and complete the survey, you will be automatically entered in a random draw to win one of five egift-cards valued at $200 each. The survey will close on 31st August 2024. #HealthResearch #PatientResearch #RareDisease #HCTD #EhlersDanlos #RVA #RareVoices #CTDNA #Marfan #LoeysDietz #Stickler

Currently, there are over 175,000 genetic tests available in the market, and the growth is expected to double by 2025. As a result, providers and health plans are facing challenges in evaluating the reliability and usefulness of these tests, while also dealing with an insufficient coding and management system. The AvalonSelect Genetic Network, a select group of preferred genetic labs coupled with robust consultative services, complements a health plan's existing routine lab network and allows health plans to continue to leverage their current lab relationships while outsourcing the management of genetic testing, pricing, compliance enforcement, test quality assessment, new test evaluation, and contracting to Avalon. Learn more: https://ow.ly/Hjvz50SMIZr #AvalonHCS #AvalonSelectGeneticNetwork #GeneticTesting #HealthPlans